BioPharma Resources

Drug Trial Radar · NCT07363694

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,156 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,156

Planned (sponsor's estimate)

Start

Feb 11, 2026

Primary completion

Oct 24, 2030

Study completion Jan 16, 2031

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 35 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 35 to 80 years old * Have had moderate-to-severe COPD for at least 12 months * Have a documented history of at least 2 moderate or severe exacerbations within the last 12 months * Have been continuously taking their regular maintenance treatment(s) for COPD over at least 6 months at a stable dose for 3 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 24 weeks for the Phase 2 part and 52 weeks for the Phase 3 part. We will compare the results of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants who will be involved in the Phase 2 part of the study for about 40 weeks. During this time, they will have 11 visits at the study clinic. Participants who will be involved in the Phase 3 part of the study for about 68 weeks. During this time, they will have 18 visits at the study clinic.

Conditions

  • Moderate to Severe Chronic Obstructive Pulmonary Disease

Interventions

  • PF-07275315 dose 1Drug

    SC injection dose 1

  • PF-07275315-dose 2Drug

    SC injection dose 2

  • PlaceboDrug

    SC injection matched

  • PF-07275315-dose 3Drug

    SC injection dose 3

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 2 part: Change from baseline in pre-bronchodilator Forced Expiratory Volume in 1 Second (FEV1) at Week 24Time frame: Baseline to Week 24
  2. Phase 3 part: Annualized rate of moderate or severe ECOPDTime frame: Baseline to Week 52

Locations

189 sites in 18 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Lung Health Center

    Birmingham, Alabama · Recruiting

  • SEC Clinical Research

    Dothan, Alabama · Recruiting

  • Pulmonary Associates of Mobile, P.C.

    Mobile, Alabama · Recruiting

  • Pulmonary Associates, PA

    Phoenix, Arizona · Recruiting

  • IMAX Clinical Trials

    La Palma, California · Recruiting

  • NewportNativeMD, Inc.

    Newport Beach, California · Recruiting

  • California Medical Research Associates

    Northridge, California · Recruiting

  • Institute of HealthCare Assessment d/b/a Apex Clinical Research

    San Diego, California · Recruiting

  • Finlay Medical Research

    Greenacres City, Florida · Recruiting

  • Clinical Research Specialists LLC

    Kissimmee, Florida · Recruiting

  • Advanced Pulmonary Research Institute

    Loxahatchee Groves, Florida · Recruiting

  • Reed Medical Research

    Miami, Florida · Recruiting

  • Renstar Medical Research

    Ocala, Florida · Recruiting

  • HCA Florida Ocala Imaging Center

    Ocala, Florida · Recruiting

  • Ocala Lung and Critical Care Associates

    Ocala, Florida · Recruiting

  • Renstar Medical Research

    Ocala, Florida · Recruiting

  • Coastal Medical Research Institute, LLC

    St. Petersburg, Florida · Recruiting

  • Coastal Pulmonary and Critical Care, P.L.C

    St. Petersburg, Florida · Recruiting

  • Clinical Research Trials of Florida, Inc.

    Tampa, Florida · Recruiting

  • Clinical Site Partners, LLC dba Flourish Research

    Winter Park, Florida · Recruiting

  • Cpcc-Research Llc

    East Point, Georgia · Recruiting

  • Centricity Research Rincon Pulmonology

    Rincon, Georgia · Recruiting

  • ASHA Clinical Research - Munster, LLC

    Hammond, Indiana · Recruiting

  • Methodist Hospital Southlake

    Merrillville, Indiana · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • Southern Clinical Research, LLC

    Zachary, Louisiana · Recruiting

  • Paul A. Shapero, MD, PA

    Bangor, Maine · Not yet recruiting

  • Exordia Medical Research Inc.

    Fall River, Massachusetts · Recruiting

  • Infinity Medical Research

    North Dartmouth, Massachusetts · Recruiting

  • Revival Research Institute, LLC

    Dearborn, Michigan · Recruiting

  • AA Medical Research Center

    Flint, Michigan · Recruiting

  • Revive Research Institute, Inc.

    Southfield, Michigan · Recruiting

  • Oakland Medical Research

    Troy, Michigan · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Barnes-Jewish Hospital Investigational Drug Service

    St Louis, Missouri · Recruiting

  • Barnes-Jewish Hospital

    St Louis, Missouri · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Washington University School-Cardiovascular Imaging and Clinical Research Core Laboratory

    St Louis, Missouri · Recruiting

  • Henderson Clinical Trials

    Henderson, Nevada · Recruiting

  • Northwell Health Physician Partners at Chappaqua

    Chappaqua, New York · Not yet recruiting

Showing 40 of 189 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.